{
  "presentation": "complete-card",
  "format_version": 3,
  "overview": "The ApoB blood test estimates the number of cholesterol-carrying particles involved in artery plaque. It can add useful risk information when a regular cholesterol panel leaves questions, but it complements that panel and a clinical assessment.",
  "overview_sources": "National Lipid Association · 2024",
  "overview_source_ids": [
    "self22b8-apob-nla-consensus"
  ],
  "sections": [
    {
      "role": "explanation",
      "title": "What ApoB measures",
      "items": [
        {
          "label": "ApoB is the protein; particles are what it helps estimate.",
          "text": "The result measures ApoB concentration, used as an indicator of the number of lipoprotein particles that can contribute to artery disease.",
          "source": "National Lipid Association · 2024",
          "source_ids": [
            "self22b8-apob-nla-consensus"
          ]
        },
        {
          "label": "LDL-C measures cargo, not how many particles carry it.",
          "text": "Each LDL particle carries one ApoB protein but a variable amount of cholesterol. Two people with the same LDL-C can therefore have different particle numbers. ApoB is reported as a protein concentration, not a literal particle tally.",
          "source": "Mayo Clinic Laboratories",
          "source_ids": [
            "self22b8-apob-mayo"
          ]
        },
        {
          "label": "It is a separately ordered blood test.",
          "text": "Quest lists ApoB as a serum test with no special preparation specified. Other tests in the same draw may have preparation instructions; confirm those with the ordering office or lab.",
          "source": "Quest Diagnostics",
          "source_ids": [
            "self22b8-apob-quest"
          ]
        },
        {
          "label": "The useful question is whether it changes the risk discussion.",
          "text": "Age, blood pressure, health habits and family history help frame the result. ApoB may add information after usual cholesterol goals are met, especially with diabetes or high triglycerides.",
          "source": "ACC · 2026",
          "source_ids": [
            "self22b8-apob-acc-2026"
          ]
        }
      ]
    },
    {
      "role": "benefits",
      "title": "What it can add",
      "items": [
        {
          "label": "It can clarify conflicting cholesterol results.",
          "text": "When ApoB and LDL-C disagree—called discordance—cardiovascular risk generally follows ApoB or non-HDL cholesterol more closely than LDL-C. ApoB adds information alongside the standard panel.",
          "source": "National Lipid Association · 2024",
          "source_ids": [
            "self22b8-apob-nla-consensus"
          ]
        },
        {
          "label": "It can help assess response to a care plan.",
          "text": "Dietary changes, other lifestyle measures and medicines can lower ApoB. Monitoring can inform treatment discussions; testing alone does not lower risk.",
          "source": "National Lipid Association · 2024",
          "source_ids": [
            "self22b8-apob-nla-thresholds"
          ]
        }
      ]
    },
    {
      "role": "cautions",
      "title": "Reading the result in context",
      "items": [
        {
          "label": "A lab flag and a treatment threshold answer different questions.",
          "text": "Mayo labels adult ApoB below 90 mg/dL desirable and 120–139 high. Those are that laboratory's categories, not a treatment goal for every reader.",
          "source": "Mayo Clinic Laboratories",
          "source_ids": [
            "self22b8-apob-mayo"
          ]
        },
        {
          "label": "There is no one target for everyone.",
          "text": "The NLA proposes different treatment-intensification thresholds by risk category and acknowledges that ApoB thresholds are less established than LDL-C thresholds. A podcast number cannot select your treatment.",
          "source": "National Lipid Association · 2024",
          "source_ids": [
            "self22b8-apob-nla-thresholds"
          ]
        },
        {
          "label": "ApoB, Lp(a) and calcium scans are different tests.",
          "text": "Lp(a) assesses a largely inherited lipoprotein risk and is generally checked at least once in adulthood. A coronary calcium scan looks for calcified plaque. These tests add to the broader assessment.",
          "source": "ACC · 2026",
          "source_ids": [
            "self22b8-apob-acc-2026"
          ]
        },
        {
          "label": "Medication choices depend on the clinical plan.",
          "text": "Statins, ezetimibe, bempedoic acid and PCSK9 antibodies are among clinical options. A single result does not decide which medicine fits, or whether to start or stop it.",
          "source": "ACC · 2026",
          "source_ids": [
            "self22b8-apob-acc-2026"
          ]
        }
      ]
    },
    {
      "role": "community",
      "title": "Getting tested and living with the number",
      "items": [
        {
          "label": "Getting an order can be the first obstacle.",
          "text": "One poster said their doctor declined ApoB and Lp(a), then asked about direct testing. Their concern was the total bill: a low advertised test price could become much higher after collection fees.",
          "source": "Community · Reddit · r/Cholesterol",
          "source_ids": [
            "self22b8-apob-reddit-order"
          ]
        },
        {
          "label": "A lower result can feel encouraging without settling treatment.",
          "text": "A poster reported ApoB falling from 104 to 70 after adding oatmeal and psyllium and eating somewhat less cheese and butter. They still questioned medication because their calcium scan and Lp(a) raised other concerns; the changes cannot prove which food caused the drop.",
          "source": "Community · Reddit · r/Cholesterol",
          "source_ids": [
            "self22b8-apob-reddit-improved"
          ]
        },
        {
          "label": "LDL can fall while ApoB barely changes.",
          "text": "Another poster reported five months of less saturated fat and more fiber: LDL-C moved from 112 to 97, while ApoB moved from 88 to 86. They felt they had little more diet change to offer and were considering a medication discussion.",
          "source": "Community · Reddit · r/Function_Health",
          "source_ids": [
            "self22b8-apob-reddit-unchanged"
          ]
        },
        {
          "label": "People disagree about replacing the lipid panel.",
          "text": "In an Attia-focused thread, some commenters dismissed other markers while others argued HDL and triglycerides still mattered. One described annual ApoB checks with more frequent standard panels. These are competing approaches, not an agreed testing schedule.",
          "source": "Community · Reddit · r/PeterAttia",
          "source_ids": [
            "self22b8-apob-reddit-panel"
          ]
        },
        {
          "label": "A simple request helps people get past over-researching.",
          "text": "Reports describe writing ApoB and Lp(a) on a note before a physical, asking whether they can join the same draw, and feeling relieved after finally requesting them.",
          "source": "Community",
          "provenance": "preserved-community-record"
        },
        {
          "label": "Comparable reports make follow-up easier.",
          "text": "People describe keeping the test date, units and lab flag together, using the same lab when possible, and noting changes in diet or medicine. Many U.S. examples use mg/dL.",
          "source": "Community",
          "provenance": "preserved-community-record"
        },
        {
          "label": "Repeat testing follows what is being evaluated.",
          "text": "Accounts mention checks about 6–12 weeks after medicine changes, then longer intervals from months to years. These are reported timelines; the clinician sets the follow-up for the actual plan.",
          "source": "Community",
          "provenance": "preserved-community-record"
        },
        {
          "label": "Low online targets can turn a lab result into anxiety.",
          "text": "Attia- and Dayspring-related discussion includes targets below 60–80 mg/dL, distinct from reported lab flags around 90–130. Some describe reassurance after a result; others keep searching for a stricter number.",
          "source": "Community",
          "provenance": "preserved-community-record"
        },
        {
          "label": "A large bloodwork report still needs interpretation.",
          "text": "Function- and Superpower-style panels feature in reports about circling the ApoB line and bringing the full PDF to a clinician. Family history, Lp(a), blood pressure and any calcium result make that conversation more useful.",
          "source": "Community",
          "provenance": "preserved-community-record"
        },
        {
          "label": "Supplement pitches can distract from follow-up.",
          "text": "Reports describe avoiding comment-section 'natural ApoB protocols' and red yeast rice ads, booking a clinical follow-up, and resisting advice to stop a statin. Diet arguments and repeated social-media checking can consume the time intended for getting help.",
          "source": "Community",
          "provenance": "preserved-community-record"
        }
      ],
      "groups": [
        {
          "title": "Getting the test and making sense of results",
          "item_indices": [
            0,
            1,
            2,
            3,
            4
          ]
        },
        {
          "title": "Comparing reports and planning follow-up",
          "item_indices": [
            5,
            6,
            8
          ]
        },
        {
          "title": "Online targets and supplement pitches",
          "item_indices": [
            7,
            9
          ]
        }
      ]
    }
  ],
  "related": [
    "lp-a",
    "home-blood-pressure",
    "function-superpower"
  ]
}
